Smart Screening.
Zero Invasion.
Your eyes tell the story.

We are developing SPECTRA-Mini — a non-invasive, eye-based screening approach designed to help detect early risk of coronary artery disease and improve access to cardiovascular assessment.

🚧 Coming soon

The problem

Coronary artery disease remains a leading cause of preventable death, yet it is often diagnosed late — particularly in regional and remote communities where access to advanced cardiac diagnostics is limited.

Current pathways rely on expensive, centralized tests and complex referrals, creating long wait times and missed opportunities for earlier intervention.

The solution

SPECTRA-Mini leverages advanced ocular imaging and data-driven analysis to extract cardiovascular insights from the eye — enabling rapid, painless screening without needles, radiation, or contrast agents.

Non-invasive

Fast & clinic-friendly

Designed for remote access

Data-driven risk insights

Clinical evidence (early): Our approach is being clinically validated against standard-of-care cardiovascular assessment pathways, with a focus on safety, accuracy, and real-world usability.

SPECTRA-Mini

A compact platform designed for primary care and community settings — bringing cardiovascular screening closer to where patients live.

Prototype concept image shown. Final design subject to iterative engineering and clinical feedback.

Designed for deployment

We’re optimizing form factor, workflow, and portability to support screening in metro, regional, and remote environments.

Portable footprint

Simple workflow

Clinic-ready UI

Scalable deployment

Want the latest updates? Email us at hadi.afsharan@gmail.com.

Why it matters

By shifting cardiovascular screening upstream, CAD SPECTRAL Technologies aims to reduce preventable heart attacks, improve health equity, and support clinicians with actionable insights earlier in the care pathway.

Expert WA-Based Team

A multidisciplinary founding team combining cardiology, optical engineering, and clinical translation — based in Western Australia.

Professor Girish Dwivedi

MD, DM, MRCP, PhD, CCST (Cardiology), FESC, FASE, FRACP

Co-Founder and CMO

Wesfarmers Chair in Cardiology, Harry Perkins Institute of Medical Research & The University of Western Australia
Consultant Cardiologist, Fiona Stanley Hospital

Assoc. Professor Barry Cense

BSc, PhD

Co-Founder and CTO

Director, Optical and Biomedical Engineering Labs (OBEL), The University of Western Australia
PhD in optical and biomedical engineering; PS-OCT expert; SPECTRA™ platform developer

Dr Hadi Afsharan

BSc, MSc, PhD

Co-Founder and CSO

Research Fellow, Harry Perkins Institute of Medical Research & The University of Western Australia
FHRI Translational Fellow; biomedical engineering and clinical translation expert